Enliven therapeutics to present at the jefferies london healthcare conference

Boulder, colo. , nov. 7, 2024 /prnewswire/ -- enliven therapeutics, inc. (enliven or the company) (nasdaq: elvn), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in a fireside chat at the jefferies london healthcare conference on tuesday, november 19, 2024, at 9:30 a.m.
ELVN Ratings Summary
ELVN Quant Ranking